U.S. Household Products Stock News

NasdaqGS:IDXX
NasdaqGS:IDXXMedical Equipment

Veralto Stock And 2 Water Testing Shares For A Cleaner Water Investment Theme

Dirty rivers and sewage headlines are turning water quality from a background issue into front-page news. With Molendotech pushing AI driven testing and real time data, attention is swinging toward companies that help measure what flows through pipes and waterways. That shift may matter for investors who care where capital goes next. This article walks through three stocks exposed to this story and what their exposure might mean for your portfolio. The stocks covered below are just a small...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Does Fox (FOXA) Balancing Higher Dividends And New Shelf Signal A Shift In Streaming Ambition?

Earlier this month, Fox Corporation reported fourth-quarter 2026 results showing sales rising to US$4,212 million while net income softened, alongside full-year revenue of US$17.13 billion and earnings per share declining from the prior year. Shortly after, Fox increased its semi-annual dividend to US$0.29 per share and filed an omnibus shelf registration for equity, preferred, and debt securities, underscoring a flexible approach to returning capital while preserving future financing...
NYSE:PACS
NYSE:PACSHealthcare

Does PACS Group’s (PACS) Higher 2026 Revenue Guidance Reframe Its Growth And Margin Trade-offs?

In early August 2026, PACS Group, Inc. reported second-quarter results showing revenue of US$1,428 million and net income of US$76.37 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. The company also raised its full-year 2026 revenue guidance to a range of US$5.75 billion to US$5.85 billion, signaling management’s increased confidence in operating performance while having executed no share repurchases under its recently...
NYSE:NE
NYSE:NEEnergy Services

Noble (NE) Eyes Offshore Drilling Recovery, Is The Stock Fully Valued?

Recent attention on Noble (NYSE:NE) centers on expectations that large offshore project pipelines in South America, West Africa, and other regions could lift ultra-deepwater drilling activity and in turn influence the company’s future revenue and EBITDA. See our latest analysis for Noble. Noble’s recent share price return of 10.6% over the past week and 8.7% over the past month, with a year to date share price return of 55.5%, suggests momentum has picked up again despite a 17.1% decline over...
NYSE:MRSH
NYSE:MRSHInsurance

Is Marsh & McLennan Companies (MRSH) Undervalued As Its 90 Day Momentum Improves?

Marsh & McLennan Companies (MRSH) has drawn investor attention after recent share price moves, with the stock now around $187.82. The company’s valuation and return profile are back under the microscope. See our latest analysis for Marsh & McLennan Companies. Over the past quarter Marsh & McLennan Companies has seen the share price rise 13.16% on a 90 day share price return basis, even though the 1 year total shareholder return is down 7.50%. This points to improving short term momentum from...
NasdaqCM:WSC
NasdaqCM:WSCConstruction

Is WillScot Holdings (WSC) Undervalued On Its Q2 Beat And Higher 2026 Outlook?

Why WillScot Holdings Stock Is Back in Focus After Q2 WillScot Holdings (WSC) is back on investors radar after Q2 results exceeded expectations, supported by strong modular activations and large project demand, alongside a higher 2026 revenue and adjusted EBITDA outlook. The company also issued updated full year guidance that points to higher expected revenue of about US$2.3b for 2026. Management framed this outlook as a reflection of ongoing commercial momentum. For investors, the...
NYSE:VTOL
NYSE:VTOLEnergy Services

How Q2 2026 Earnings At Bristow Group (VTOL) Have Changed Its Investment Story

Bristow Group Inc. has reported its past second-quarter 2026 results, posting sales of US$411.76 million and net income of US$21.15 million, with basic earnings per share from continuing operations of US$0.71 and diluted earnings per share of US$0.70. These figures offer fresh insight into Bristow’s recent operating performance and earnings quality, an important reference point for assessing its longer-term contract- and technology-led plans. We’ll now examine how this second-quarter...
NasdaqGS:MMYT
NasdaqGS:MMYTHospitality

Does MakeMyTrip’s Q1 Revenue Growth With Weaker EPS Reshape The Bull Case For MMYT?

MakeMyTrip Limited has released its first-quarter 2026 results, reporting sales of US$151.18 million and total revenue of US$285.58 million, with net income of US$8.35 million for the three months ended June 30, 2026. While revenue increased compared with a year earlier, the fall in net income and earnings per share points to pressure on costs and profitability that may prompt investors to reassess the quality of the company’s growth. We’ll now examine how this revenue growth alongside...
NYSE:MTRN
NYSE:MTRNMetals and Mining

Robust Q2 2026 Earnings Momentum Could Be A Game Changer For Materion (MTRN)

Materion Corporation recently reported past second-quarter 2026 results, with sales rising to US$613.91 million and net income to US$38.76 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. For the first half of 2026, Materion’s sales grew to US$1.16 billion with net income of US$58.13 million, underscoring continued improvement in profitability across its operations. We’ll now explore how Materion’s strong year-over-year sales...
NYSE:GMED
NYSE:GMEDMedical Equipment

Is Revenue Growth Amid Margin Pressure Altering The Investment Case For Globus Medical (GMED)?

In the past week, Globus Medical, Inc. reported second-quarter 2026 results showing sales of US$789.61 million, up from US$745.34 million a year earlier, while net income declined to US$151.57 million from US$202.85 million and diluted EPS fell to US$1.10 from US$1.49. Over the first half of 2026, the company grew sales to US$1.55 billion from US$1.34 billion with largely flat net income, and reaffirmed its full-year revenue outlook of US$3.18 billion to US$3.22 billion, highlighting solid...
NYSE:RHI
NYSE:RHIProfessional Services

Is Robert Half (RHI) Fully Valued Following Its Buyback Completion And Dividend Update?

Robert Half (RHI) has closed a long running capital return chapter. The company reported that it has now completed the share repurchase program launched in February 2018, alongside affirming its regular quarterly dividend. See our latest analysis for Robert Half. At a share price of $43.22, Robert Half has seen a 90 day share price return of 65.09% and a year to date share price return of 58.08%, while the 5 year total shareholder return is down 48.82%. This suggests that recent momentum has...
NYSE:RLJ
NYSE:RLJHotel and Resort REITs

The Bull Case For RLJ Lodging Trust (RLJ) Could Change Following Strong Q2 Results And Raised 2026 Outlook

In August 2026, RLJ Lodging Trust reported past second-quarter 2026 results showing higher sales of US$311.76 million and revenue of US$382.99 million, with net income rising to US$31.04 million and diluted EPS from continuing operations improving to US$0.16. Alongside these results, RLJ raised its full-year 2026 net income outlook to a range of US$21.6 million to US$38.6 million, pointing to continued benefits from business travel recovery and recent lifestyle-focused hotel conversions. Now...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Ocular Therapeutix (OCUL) Is Up 9.2% After Wider Q2 Loss and New US$81.7M Shelf Registration

In August 2026, Ocular Therapeutix reported second-quarter 2026 results showing essentially flat revenue at US$13.48 million year over year, while net loss widened to US$78.76 million and the company also filed an US$81.7 million shelf registration for up to 10,000,000 common shares in an ESOP-related offering. The combination of a larger loss despite slightly improved per-share metrics, alongside preparation for additional equity issuance, raises fresh questions about the company’s funding...
NYSE:CCI
NYSE:CCISpecialized REITs

Crown Castle (CCI) Affirms Its Dividend, Is The 21% Undervaluation Case Convincing?

Crown Castle (CCI) recently affirmed its income focus, with the Board declaring a quarterly cash dividend of $1.0625 per share. The dividend is payable on September 30, 2026, to stockholders of record on September 15. See our latest analysis for Crown Castle. Crown Castle’s latest dividend decision comes after a tougher share price stretch, with the stock at $75.98 and a 90 day share price return down 15.5% and a 5 year total shareholder return down 51.21%. This signals fading momentum...
NYSE:GFF
NYSE:GFFBuilding

The Bull Case For Griffon (GFF) Could Change Following New 2034 Notes, Buybacks And Dividend Plan

In August 2026, Griffon Corporation priced an unregistered US$800 million offering of senior unsecured notes due 2034 at a 6.25% coupon to help redeem its outstanding 5.75% senior notes due 2028, alongside maintaining 2026 revenue guidance of US$1.8 billion and declaring a US$0.22 quarterly dividend. The combination of refinancing its debt stack, ongoing share repurchases totaling US$707.63 million since 2016, and sharply improved quarterly earnings highlights management’s focus on...
NYSE:WRBY
NYSE:WRBYSpecialty Retail

Warby Parker (WRBY), What Is Behind The Fresh Attention Now?

Warby Parker (WRBY) is back in focus after its second quarter 2026 earnings release sparked a negative share price reaction, despite reaffirmed full year revenue guidance and plans to increase marketing ahead of an Intelligent Eyewear launch. See our latest analysis for Warby Parker. Against that backdrop, Warby Parker’s share price has eased over the past quarter, with a 90 day share price return of a 9.56% decline contrasting with a 14.54% gain year to date, while the 3 year total...
NYSE:ANRO
NYSE:ANROPharmaceuticals

Is Alto Neuroscience (ANRO) Fully Valued As ALTO 207 Expands With New Funding?

Alto Neuroscience (ANRO) has moved back into focus after expanding its ALTO-207 program with an additional Phase 3 trial for treatment-resistant depression, supported by fresh funding and independent mechanism-of-action data. See our latest analysis for Alto Neuroscience. The latest ALTO-207 update comes after a period of strong momentum for Alto Neuroscience, with a year-to-date share price return of 93.73% and a 1-year total shareholder return of about 9.2 times an initial investment. The...
NYSE:GXO
NYSE:GXOLogistics

GXO Logistics (GXO) Returned To Profitability, Is The Stock Still Undervalued?

GXO Logistics (GXO) just released second quarter and first half 2026 results, with sales of US$3,441 million for the quarter and a return to profitability over six months attracting fresh attention. See our latest analysis for GXO Logistics. The latest results come after a mixed stretch for GXO Logistics, with the share price at US$48.58 and a 1 year total shareholder return that declined 7.55%, while the 3 year total shareholder return fell 21.19% and the 5 year total shareholder return...
NYSE:SEI
NYSE:SEIEnergy Services

Solaris Energy (SEI) Is Up 9.2% After Q2 Beat And 32nd Straight Dividend Payout

Solaris Energy Infrastructure, Inc. recently reported second-quarter 2026 results, with sales rising to US$105.72 million and net income reaching US$20.49 million, while also affirming a third-quarter dividend of US$0.12 per share, marking its 32nd consecutive dividend. A key twist in the results is that, despite higher net income and revenue, diluted earnings per share from continuing operations eased to US$0.26, reflecting the impact of share count and capital structure changes. Against...
NYSE:CUZ
NYSE:CUZOffice REITs

Cousins Properties (CUZ) Has Investors Asking A Bigger Question

Cousins Properties (CUZ) has been drawing attention after recent share price moves, with the stock closing at US$29.70 on 13 August 2026. Investors are weighing this level against its broader performance trends. See our latest analysis for Cousins Properties. At US$29.70, Cousins Properties has given investors a mixed ride, with the share price return up 12.84% over 90 days and 14.58% year to date, while the 30 day share price return is down 6.49%. Over longer horizons, the 1 year total...
NasdaqGS:LFUS
NasdaqGS:LFUSElectronic

Littelfuse (LFUS) Stock May Be Cheap On Cash Flow But Rich On Sales

Littelfuse stock has surged over the past year, yet the valuation signals are mixed, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while market multiples imply the shares are priced on the rich side. Littelfuse has delivered a 84.4% return over the past year, which sets a high bar for any further upside to be justified by fundamentals. Expectations for continued cash flow generation can support the DCF case for upside. However, any pressure on margins or a...
NasdaqGS:RRR
NasdaqGS:RRRHospitality

Red Rock Resorts (RRR) Shares Just Moved, So What Is Driving Attention Now?

Red Rock Resorts (RRR) is back in focus after reporting second quarter 2026 results that showed softer revenue and earnings, along with a newly declared cash dividend, giving investors fresh numbers to reassess the stock. See our latest analysis for Red Rock Resorts. Despite the softer second quarter results and the new dividend announcement, Red Rock Resorts shares have shown building momentum, with a 22.14% 90 day share price return and a 69.06% three year total shareholder return. If this...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

Nova (NVMI) Could Be 27% Undervalued On Q2 Earnings And Q3 Guidance

Nova earnings and guidance set the tone for investors Nova (NasdaqGS:NVMI) has put fresh numbers on the table with its second quarter and first half 2026 results, along with new third quarter guidance that gives investors updated revenue and earnings expectations. See our latest analysis for Nova. Novo's latest earnings and guidance have come alongside a share price of $418.12, with a 7 day share price return of 6.39% and a 90 day share price return that is down 14.10%. Even so, total...
NYSE:IRM
NYSE:IRMSpecialized REITs

Iron Mountain (IRM) Is Up 6.8% After Raising 2026 Revenue Guidance - Has The Bull Case Changed?

Iron Mountain Incorporated recently reported second-quarter 2026 results showing revenue of US$2,029.06 million and net income of US$101.43 million, a return to profitability versus a net loss a year earlier. The company also raised its full-year 2026 total revenue guidance to a range of US$7.94 billion to US$8.01 billion, signaling greater confidence in its operating performance and growth plans. With Iron Mountain lifting full-year revenue guidance after a profitable quarter, we’ll now...